Page last updated: 2024-09-03

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and diazepam

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with diazepam in 4 studies

*Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. [MeSH]

*Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. [MeSH]

Compound Research Comparison

Studies
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)
Trials
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)
Recent Studies (post-2010)
(1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)
Studies
(diazepam)
Trials
(diazepam)
Recent Studies (post-2010) (diazepam)
260518,3772,3291,790

Protein Interaction Comparison

ProteinTaxonomy1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone (IC50)diazepam (IC50)
Gamma-aminobutyric acid receptor subunit piHomo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit deltaHomo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit alpha-1Bos taurus (cattle)0.0266
Gamma-aminobutyric acid receptor subunit beta-1Bos taurus (cattle)0.0266
Gamma-aminobutyric acid receptor subunit alpha-2Bos taurus (cattle)0.0266
Gamma-aminobutyric acid receptor subunit alpha-3Bos taurus (cattle)0.0266
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit beta-1Homo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)0.0124
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)0.0108
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0227
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit alpha-4Bos taurus (cattle)0.0266
Gamma-aminobutyric acid receptor subunit gamma-2Bos taurus (cattle)0.0266
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)0.0106
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)0.0124
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit alpha-5Homo sapiens (human)0.0124
Gamma-aminobutyric acid receptor subunit alpha-3Homo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit alpha-4Homo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit epsilonHomo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit alpha-6Homo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit gamma-1Homo sapiens (human)0.0101
GABA theta subunitRattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit gamma-3Homo sapiens (human)0.0101
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)0.0108
Gamma-aminobutyric acid receptor subunit thetaHomo sapiens (human)0.0101

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, JE; Helton, DR; Rasmussen, K; Scearce, E2
Berger, JE; Czachura, JF; Helton, DR; Kallman, MJ; Rasmussen, K1
Bradwejn, J; Harro, J; Oreland, L; Vasar, E1

Other Studies

4 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and diazepam

ArticleYear
The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle.
    Neuroreport, 1993, Nov-18, Volume: 5, Issue:2

    Topics: Acoustic Stimulation; Animals; Cholecystokinin; Diazepam; Male; Pyrazoles; Rats; Reflex, Startle; Substance Withdrawal Syndrome

1993
The CCK-B antagonist LY288513 blocks diazepam-withdrawal-induced increases in auditory startle response.
    Annals of the New York Academy of Sciences, 1994, Mar-23, Volume: 713

    Topics: Acoustic Stimulation; Animals; Cholecystokinin; Diazepam; Male; Pyrazoles; Rats; Receptors, Cholecystokinin; Reflex, Startle; Substance Withdrawal Syndrome; Time Factors

1994
Central nervous system characterization of the new cholecystokininB antagonist LY288513.
    Pharmacology, biochemistry, and behavior, 1996, Volume: 53, Issue:3

    Topics: Animals; Behavior, Animal; Central Nervous System; Diazepam; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Mice; Mice, Inbred Strains; Motor Activity; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Time Factors

1996
Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1995, Volume: 5, Issue:4

    Topics: Adrenergic Agents; Animals; Anti-Anxiety Agents; Anxiety; Benzylamines; Diazepam; Exploratory Behavior; Female; Hormone Antagonists; Male; Norepinephrine; Pyrazoles; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sex Characteristics; Sympathectomy, Chemical

1995